News Focus
News Focus
Followers 42
Posts 22344
Boards Moderated 2
Alias Born 07/10/2015

Re: boston745 post# 41743

Thursday, 11/14/2024 10:08:37 PM

Thursday, November 14, 2024 10:08:37 PM

Post# of 42727

About time for the annual meeting filing. Be curious what will be on it? Should include a new vote on employee share plan since last years plan was voted down conveniently before a massive RS.


They just filed the annual meeting and it includes the new employee share plan expansion of shares. What direction that goes will give us an idea if there will be a RS next year into 2026 as some accounts like to invoke. If it fails theres a high chance of a RS. If it passes, which I expect, then RS is unlikely. I do not like how this is going down but you'll hear no argument from me that management & its employees deserves shares for the value they have created; even though that value is not currently reflected by the stock price. The sheer expansion of scope of IP is grounds enough in my opinion. Looks like the employee plan will give employees up to 20% of current outstanding shares when factoring in these new ones increasing OS to 1.6m if fully distributed because of a change in control.

Second filing today was Lind Partners indicating that they have 35,750 series E & 35,750 Series F warrants. The exercise price of those warrants should be 50 dollars. The Series F warrants expire August 2025. If they exercised those fully thats $3.6m unless they do some sort of cashless exercise.

The Class E and Class F Warrants were immediately exercisable at a price of $50.00 per share.




Lind is part of Ansons family of hedge funds that have been shorting and distorting on and off here since 2015 and played the pump in 2020 via Sabby fund. Here is the list of funds with all the funds in red being funds that have participated in Sintx offerings through the years.

Plaintiff further asserts that many of the potential investors that it contacted on behalf of Defendant operate as a family of hedge funds, all managed by the same investment advisor.



List of potential investors the Plaintiff was referencing. All the funds that seem to be connected are in red.

List named the following:
Anson Funds Management LP and its affiliates
Ayrton Capital, Altos Opportunity Fund and their
affiliates
Crede Capital Group, Acquitas Capital and its affiliates
CVI Investment, Heights Management, SIG and their
affiliates
Connective Capital and its affiliates
Empery Asset Management and its affiliates
Intracoastal Capital LP and its affiliates
Hudson Bay Capital Management and its affiliates
Ionic Venture LLC and its affiliates
Lind Partners and its affiliates
Li Capital Global Opportunities Master Fund and their
affiliates
Sabby Management LLC and its affiliates



Quote Sources 2&3
https://www.sec.gov/ix?doc=/Archives/edgar/data/1269026/000149315224044728/form10-q.htm pg 9
https://images.law.com/contrib/content/uploads/documents/404/140289/51-2023-08-31-043-Order-Denying-SJMotion.pdf

========================================

Here is a collection of my research going over multiple subjects including Sintx connections with Zimmer Biomet, Solventum, Morgan Ceramics, & NP Aerospace. Includes other research topics as well.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175357996

========================================

We already know Sintx and Morgan were working together. If there is going to be some sort of NP/Sintx merger, that just solidifies it. We also know Zimmer Biomet and Sintx have had a long standing relationship (going on 20 years) so as long as Sintx components for Arthroplasty are any good, Zimmer Biomet will come out from behind the curtain. With ZB comes ZimVie and I believe Solventum because of Bryan Hanson. Leaving only Cardinal Health which is suggested by Sintx hiring of Joseph Palomo who joined Sintx from Cardinal Health R&D division.

Morgan Ceramics = Aerospace products
Zimmer Biomet = Arthroplasty oriented products
ZimVie = Dental?
Solventum = Wound Care, Catheters, & possibly Cancer treatment products.
Cardinal Health = PPE & Medical protection apparel.
NP Aerospace = Armor plates & other possible products connected to TA&T.

========================================

Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn

Total = $324.26bn

Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market

https://investorshub.advfn.com/Bostons-research-43724
Could it be that there is a strategy to distract people away from looking at basic data?
Is it an exercise to create forum verbiage to drown out any serious discussion of evidence?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News